Xencor Inc

Healthcare · Biotechnology

24.40$ -5.0% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Xencor Inc (XNCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 725 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XNCR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	322	429	418	416	398	390	612	591	586	577	697	685	686	670	667	645	646	703	693	696	697	838	858	851	835	846	803	778	778	965	897	826	984	952	905	879	869	875	737	725
Current Assets	111	142	166	211	218	231	471	270	287	316	489	527	574	558	588	603	571	638	591	481	330	424	506	586	668	675	630	594	571	636	575	554	573	578	521	513	518	600	483	523
Cash	15	15	14	11	14	17	252	35	35	26	22	33	51	50	74	110	58	164	177	116	41	143	78	49	53	54	72	35	53	54	31	31	29	41	40	44	28	54	14	45
Cash & Short-Term Investments	104	130	155	188	210	224	462	255	272	294	340	505	546	527	574	586	551	603	552	450	288	334	390	512	600	623	588	551	495	594	536	508	543	498	470	444	471	548	445	456
Receivables	3.1	8.6	6.9	15	0.8	1.1	1.9	2.0	2.5	10	139	11	20	25	6.8	9.7	9.5	24	25	15	21	66	93	54	45	29	20	20	55	24	22	22	10	61	38	48	22	29	12	42
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	0.0	–	0.0	0.0	0.0	0.0	–	0.0	0.0	–	–	–	–	–	0.0	0.0	0.0	–	–	0.0	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	3.1	3.1	3.4	3.9	6.1	7.1	8.9	9.4	9.7	12	11	12	14	16	17	16	20	22	22	23	24	60	28	39	51	94	67	68	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	11	10	11	11	11	11	11	12	12	12	13	14	14	14	15	15	15	16	16	16	17	16	17	18	18	19	18	19	19	19	19	19	18	18	13	11	9.5	8.4	7.6	6.5
Total Liabilities	120	115	115	115	108	108	75	72	53	55	87	77	76	77	74	74	78	131	109	49	78	105	95	109	113	119	120	99	109	303	297	264	263	278	265	259	243	240	221	222
Current Liabilities	111	106	107	107	100	101	73	71	52	54	73	64	64	67	66	66	70	121	100	46	44	71	61	75	90	64	65	45	53	74	71	80	92	87	88	96	86	96	73	82
Short-Term Debt	0.4	6.7	0.2	0.5	4.6	5.5	–	5.9	5.7	9.7	2.0	2.2	2.2	2.2	2.1	2.1	2.2	1.9	1.9	2.3	0.1	34	0.9	7.6	21	4.7	4.5	4.2	4.4	31	36	8.2	9.9	51	3.6	3.4	49	47	30	3.9
Accounts Payable	7.3	3.9	4.3	7.4	11	6.9	8.5	4.9	6.0	3.8	5.5	9.0	8.3	10	10	11	13	9.0	7.7	7.1	9.1	14	12	16	15	10	15	14	15	14	16	16	19	17	16	19	9.1	11	7.9	13
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	10	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	15	12	12	10	115	–	95	–	76	82	78
Shareholders' Equity	202	314	304	301	291	282	538	519	532	522	610	608	610	593	593	571	568	572	584	647	619	734	763	742	723	727	684	679	669	662	600	564	724	678	640	620	625	636	516	503
Retained Earnings	-229	-238	-253	-260	-275	-287	-282	-308	-305	-323	-243	-259	-269	-296	-304	-339	-352	-366	-368	-316	-356	-283	-260	-293	-326	-338	-399	-421	-445	-471	-545	-598	-644	-704	-752	-783	-789	-796	-925	-947
Shares Outstanding	41	43	47	47	47	47	48	56	58	56	58	56	57	57	57	57	57	58	58	60	58	60	61	60	60	60	60	60	61	61	61	62	64	73	74	74	74	74	75	76

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings